Molecular dynamics simulation of β 2-microglobulin in denaturing and stabilizing conditions

Proteins: Structure, Function and Bioinformatics

Volumn 79, Issue 3, 2011, Pages 986-1001

  Fogolari, Federico ^a,b   Corazza, Alessandra ^a,b   Varini, Nicola ^c   Rotter, Matteo ^a   Gumral, Devrim ^a   Codutti, Luca ^a,b   Rennella, Enrico ^a   Viglino, Paolo ^a,b   Bellotti, Vittorio ^b,d   Esposito, Gennaro ^a,b  

^a UNIVERSITY OF UDINE   (Italy)

^b NATIONAL INSTITUTE OF BIOSTRUCTURES AND BIOSYSTEMS   (Italy)

^c CINECA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

Cis trans isomerization; Doxycycline; Low pH; Tetracycline; TFE

Indexed keywords

AMYLOID; BETA 2 MICROGLOBULIN; COLLAGEN FIBRIL; DOXYCYCLINE; PROLINE; TRIFLUOROETHANOL;

ADULT; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; HUMAN; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DENATURATION; PROTEIN SECONDARY STRUCTURE; PROTEIN STABILITY; TRANS ISOMER;

BETA 2-MICROGLOBULIN; HYDROGEN-ION CONCENTRATION; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; PROTEIN DENATURATION;

EID: 79551496525     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22940     Document Type: Article

References (90)

1. Porcelli SA, Modlin RL. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu Rev Immunol 1999; 17: 297329.
2. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC. Structure of the human class I histocompatibility antigen, HLA-A2. Nature 1987; 329: 506-512.
3. Verdone G, Corazza A, Viglino P, Pettirossi F, Giorgetti S, Mangione P, Andreola A, Stoppini M, Bellotti V, Esposito G. The solution structure of human beta2-microglobulin reveals the prodromes of its amyloid transition. Protein Sci 2002; 11: 487-499.
4. Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T. A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun 1985; 129: 701-706.
5. Yamamoto S, Gejyo F. Historical background and clinical treatment of dialysis-related amyloidosis. Biochim Biophys Acta 2005; 1753: 4-10.
6. Dobson CM. Protein misfolding, evolution and disease. Trends Biochem Sci 1999; 9: 329-332.
7. Dobson CM, Karplus M. The fundamentals of protein folding: bringing together theory and experiment. Curr Opin Struct Biol 1999; 9: 92-101.
8. Chiti F, Dobson CM. Amyloid formation by globular proteins under native conditions. Nat Chem Biol 2009; 5: 15-22.
9. Chiti F, Mangione P, Andreola A, Giorgetti S, Stefani M, Dobson CM, Bellotti V, Taddei N. Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin. J Mol Biol 2001; 307: 379-391.
10. Chiti F, De Lorenzi E, Grossi S, Mangione P, Giorgetti S, Caccialanza G, Dobson CM, Merlini G, Ramponi G, Bellotti V. A partially structured species of beta 2-microglobulin is significantly populated under physiological conditions and involved in fibrillogenesis. J Biol Chem 2001; 276: 46714-46721.
11. Kameda A, Hoshino M, Higurashi T, Takahashi S, Naiki H, Goto Y. Nuclear magnetic resonance characterization of the refolding intermediate of beta2-microglobulin trapped by non-native prolyl peptide bond. J Mol Biol 2005; 348: 383-397.
12. Sakata M, Chatani E, Kameda A, Sakurai K, Naiki H, Goto Y. Kinetic coupling of folding and prolyl isomerization of beta2-microglobulin studied by mutational analysis. J Mol Biol 2008; 382: 1242-1255.
13. Kameda A, Morita EH, Sakurai K, Naiki H, Goto Y. NMR-based characterization of a refolding intermediate of beta2-microglobulin labeled using a wheat germ cell-free system. Protein Sci 2009; 18: 1592-1601.
14. Corazza A, Rennella E, Schanda P, Mimmi MC, Cutuil T, Raimondi S, Giorgetti S, Fogolari F, Viglino P, Frydman L, Gal M, Bellotti V, Brutscher B, Esposito G. Native-unlike long-lived intermediates along the folding pathway of the amyloidogenic protein beta2-microglobulin revealed by real-time two-dimensional NMR. J Biol Chem 2010; 285: 5827-5835.
15. Chiti F, Webster P, Taddei NAC, Stefani M, Ramponi G, Dobson CM. Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Natl Acad Sci USA 1999; 96: 3590-3594.
16. Yamaguchi K, Naiki H, Goto Y. Mechanism by which the amyloid-like fibrils of a beta 2-microglobulin fragment are induced by fluorine-substituted alcohols. J Mol Biol 2006; 363: 279-288.
17. Naiki H, Hashimoto N, Suzuki S, Kimura H, Nakakuki K, Gejyo F. Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro. Amyloid Int J of Exp Clin Invest 1997; 4: 223-232.
18. 2-microglobulin studied by replica-exchange molecular dynamics simulations- towards the understanding of the mechanism of amyloid formation. FEBS Lett 2005; 579: 5425-5429.
19. Standley DM, Yonezawa Y, Goto Y, Nakamura H. Flexible docking of an amyloid-forming peptide from beta(2)-microglobulin. FEBS Lett 2006; 580: 6199-6205.
20. Lei H, Wu C, Wang Z, Duan Y. Molecular dynamics simulations and free energy analyses on the dimer formation of an amyloidogenic heptapeptide from human beta2-microglobulin: implication for the protofibril structure. J Mol Biol 2006; 356: 1049-1063.
21. Liang C, Derreumaux P, Wei G. Structure and aggregation mechanism of beta(2)-microglobulin (83-99) peptides studied by molecular dynamics simulations. Biophys J 2007; 93: 3353-3362.
22. Liang C, Derreumaux P, Mousseau N, Wei G. The beta-strand-loop-beta-strand conformation is marginally populated in beta2-microglobulin (20-41) peptide in solution as revealed by replica exchange molecular dynamics simulations. Biophys J 2008; 95: 510-517.
23. Song W, Wei G, Mousseau N, Derreumaux P. Self-assembly of the beta2-microglobulin NHVTLSQ peptide using a coarse-grained protein model reveals a beta-barrel species. J Phys Chem B 2008; 112: 4410-4418.
24. Zheng J, Jang H, Nussinov R. Beta2-microglobulin amyloid fragment organization and morphology and its comparison to Abeta suggests that amyloid aggregation pathways are sequence specific. Biochemistry 2008; 47: 2497-2509.
25. Lu Y, Derreumaux P, Guo Z, Mousseau N, Wei G. Thermodynamics and dynamics of amyloid peptide oligomerization are sequence dependent. Proteins 2009; 75: 954-963.
26. Fang PS, Zhao JH, Liu HL, Liu KT, Chen JT, Lin HY, Huang CH, Fang HW. Molecular dynamics simulations to gain insights into the stability and morphologies of K3 oligomers from beta2-microglobulin. J Biomol Struct Dyn 2009; 26: 549-559.
27. Mustata M, Capone R, Jang H, Arce F, Ramachandran S, Lal R, Nussinov R. K3 fragment of amyloidogenic beta(2)-microglobulin forms ion channels: implication for dialysis related amyloidosis. J Am Chem Soc 2009; 131: 1493814945.
28. Ivanova MI, Sawaya MR, Gingery M, Attinger A, Eisenberg D. An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. Proc Natl Acad Sci USA 2004; 101: 10584-10589.
29. Ivanova MI, Thompson MJ, Eisenberg D. A systematic screen of beta(2)-microglobulin and insulin for amyloid-like segments. Proc Natl Acad Sci USA 2006; 103: 4079-4082.
30. Kozhukh GV, Hagihara Y, Kawakami T, Hasegawa K, Naiki H, Goto Y. Investigation of a peptide responsible for amyloid fibril formation of beta 2-microglobulin by achromobacter protease I. J Biol Chem 2002; 277: 1310-1315.
31. Iwata K, Fujiwara T, Matsuki Y, Akutsu H, Takahashi S, Naiki H, Goto Y. 3D structure of amyloid protofilaments of beta2-microglobulin fragment probed by solid-state NMR. Proc Natl Acad Sci USA 2006; 103: 18119-18124.
32. Sugita Y, Okamoto Y. Replica-exchange molecular dynamics method for protein folding. Chem Phys Lett 1999; 314: 141-151.
33. Onufriev A, Case DA, Bashford D. Effective Born radii in the generalized Born approximation: the importance of being perfect. J Comput Chem 2002; 23: 1297-1304.
34. Derreumaux P. From polypeptide sequences to structures using Monte Carlo simulations and an optimized potential. J Chem Phys 1999; 111: 2301-2310.
35. Fogolari F, Corazza A, Viglino P, Zuccato P, Pieri L, Faccioli P, Bellotti V, Esposito G. Molecular dynamics simulation suggests possible interaction patterns at early steps of beta2-microglobulin aggregation. Biophys J 2007; 92: 1673-1681.
36. Esposito G, Ricagno S, Corazza A, Rennella E, Gmral D, Mimmi MC, Betto E, Pucillo CE, Fogolari F, Viglino P, Raimondi S, Giorgetti S, Bolognesi B, Merlini G, Stoppini M, Bolognesi M, Bellotti V. The controlling roles of Trp60 and Trp95 in beta2-microglobulin function, folding and amyloid aggregation properties. J Mol Biol 2008; 378: 887-897.
37. 2-microglobulin and its variants. Prot Eng 2003; 16: 2310-2321.
38. Deng NJ, Yan L, Singh D, Cieplak P. Molecular basis for the Cu2+ binding-induced destabilization of beta2-microglobulin revealed by molecular dynamics simulation. Biophys J 2006; 90: 3865-3879.
39. Park S, Saven JG. Simulation of pH-dependent edge strand rearrangement in human beta-2 microglobulin. Protein Sci 2006; 15: 200-207.
40. Armen RS, deMarco ML, Alonso DOV, Daggett V. Pauling and Corey's alpha-pleated sheet structure may define the prefibrillar amyloidogenic intermediate in amyloid disease. Proc Natl Acad Sci USA 2004; 101: 11622-11627.
41. 2-microglobulin unfolding intermediates that may lead to amyloid fibrils of different morphology. Biochemistry 2005; 44: 16098-16107.
42. Fang PS, Zhao JH, Liu HL, Liu KT, Chen JT, Tsai W.-B., Lin HY, Fang HW, Huang CH, Ho Y. Molecular dynamics simulations to investigate the relationship between the structural stability and amyloidogenesis of the wild-type and N-terminal hexapeptide deletion Δ N6 β2-microglobulin. Mol Simul 2009; 35: 755-765.
43. Rosano C, Zuccotti S, Bolognesi M. The three-dimensional structure of beta2 microglobulin: results from X-ray crystallography. Biochim Biophys Acta 2005; 1753: 85-91.
44. 2-microglobulin amyloidosis: insights from conservation analysis and fibril modelling by protein docking techniques. J Mol Biol 2003; 330: 159-174.
45. 2-microglobulin amyloidosis. Biochim Biophys Acta 2005; 330: 121-130.
46. Saper MA, Bjorkman PJ, Wiley DC. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J Mol Biol 1991; 219: 277-319.
47. Berendsen HJC, van der Spoel D, van Drunen R. Gromacs: A message-passing parallel molecular dynamics implementation. Comp Phys Comm 1995; 91: 43-56.
48. Kale L, Skeel R, Bhandarkar M, Brunner R, Gursoy A, Krawetz N, Phillips J, Shinozaki A, Varadarajan K, Schulten K. NAMD2: greater scalability for parallel molecular dynamics. J Comp Phys 1999; 151: 283-312.
49. Van Buuren AR, Berendsen HJ. Molecular dynamics simulation of the stability of a 22-residue alpha-helix in water and 30% trifluoroethanol. Biopolymers 1993; 33: 1159-1166.
50. Fioroni M, Berger K, Mark AE, Roccatano D. A new 2, 2, 2-trifluoroethanol model for molecular dynamics simulations. J Phys Chem B 2000; 104: 12347-12354.
51. Chitra R, Smith PE. Properties of 2, 2, 2-trifluoroethanol and water mixtures. J Chem Phys 2001; 114: 426-435.
52. Jalili S, Akhavan M. Molecular dynamics simulation study of association in trifluoroethanol/water mixtures. J Comput Chem 2010; 31: 286-294.
53. Chitra R, Smith PE. A comparison of the properties of 2, 2, 2-trifluoroethanol and 2, 2, 2-trifluoroethanol/water mixtures using different forcefields. J Chem Phys 2001; 115: 5521-5530.
54. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M. CHARMM: A program for macromolecular energy minimization and dynamics calculations. J Comput Chem 1983; 4: 187-217.
55. MacKerell ADJ, Bashford D, Bellott M, Dunbrack RLJ, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher WEI, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiorkiewicz-Kuczera J, Yin D, Karplus M. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 1998; 102: 3586-3616.
56. Chen I, Yin D, MacKerell ADJ. Combined ab initio/empirical approach for optimization of lennard-jones parameters for polar-neutral compounds. J Comput Chem 2002; 23: 199-213.
57. Berendsen HJC, Grigera JR, Straatsma TP. The missing term in effective pair-potentials. J Phys Chem 1987; 91: 6269-6271.
58. van der Spoel D, van Maaren PJ, Berendsen HJC. A systematic study of water models for molecular simulation: Derivation of water models optimized for use with a reaction field. J Phys Chem 1998; 108: 10220-10230.
59. Tarek M, Tobias DJ. The dynamics of protein hydration water: a quantitative comparison of molecular dynamics simulations and neutron-scattering experiments. Biophys J 2000; 79: 3244-3257.
60. Paschek D. Temperature dependence of the hydrophobic hydration and interaction of simple solutes: An examination of five popular water models. J Chem Phys 2004; 120: 6674-6690.
61. Shirts MR, Pande VS. Solvation free energies of amino acid side chain analogs for common molecular mechanics water models. J Chem Phys 2005; 122: 134508.
62. Aleksandrov A, Simonson T. Molecular mechanics models for tetracycline analogs. J Comput Chem 2009; 30: 243-255.
63. MacKerell AD, Feig M, Brooks CL. Extending the treatment of backbone energetics in protein force fields: limitations of gas-phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem 2004; 25: 1400-1415.
64. Darden T, York D, Pedersen L. Particle Mesh Ewald. An N.log(N) method for Ewald sums in large systems. J Chem Phys 1993; 98: 10089-10092.
65. Keutsch FN, Saykally RJ. Water clusters: untangling the mysteries of the liquid, one molecule at a time. Proc Natl Acad Sci USA 2001; 98: 10533-10540.
66. Berendsen HJC, Postma JPM, van Gunsteren WF, Di Nola A, Haak JR. Molecular dynamics with coupling to an external bath. J Chem Phys 1984; 81: 3684-3690.
67. Kang YK. Conformational preferences of non-prolyl and prolyl residues. J Phys Chem B 2006; 110: 21338-21348.
68. Yonezawa Y, Nakata K, Sakakura K, Takada T, Nakamura H. Intra- and intermolecular interaction inducing pyramidalization on both sides of a proline dipeptide during isomerization: an ab initio QM/MM molecular dynamics simulation study in explicit water. J Am Chem Soc 2009; 131: 4535-4540.
69. McDonald DQ, Still WC. Molecular mechanics parameters and conformational free energies of proline-containing peptides. J Org Chem 1996; 61: 1385-1391.
70. Hur S, Bruice TC. The mechanism of cis-trans isomerization of prolyl peptides by cyclophilin. J Am Chem Soc 2002; 124: 7303-7313.
71. Hamelberg D, Shen T, McCammon JA. Phosphorylation effects on cis/trans isomerization and the backbone conformation of serine-proline motifs: accelerated molecular dynamics analysis. J Am Chem Soc 2005; 127: 1969-1974.
72. Trzesniak D, van Gunsteren WF. Catalytic mechanism of cyclophilin as observed in molecular dynamics simulations: pathway prediction and reconciliation of X-ray crystallographic and NMR solution data. Protein Sci 2006; 15: 2544-2551.
73. Mark P, Nilsson L. A molecular dynamics study of Cyclophilin A free and in complex with the Ala-Pro dipeptide. Eur Biophys J 2007; 36: 213-224.
74. Hamelberg D, McCammon JA. Mechanistic insight into the role of transition-state stabilization in cyclophilin A. J Am Chem Soc 2009; 131: 147-152.
75. Darve E, Pohorille A. Calculating free energies using average force. J Chem Phys 2001; 115: 9169-9183.
76. Hnin J, Chipot C. Overcoming free energy barriers using unconstrained molecular dynamics simulations. J Chem Phys 2004; 121: 2904-2914.
77. Darve E, Rodriguez-Gomez D, Pohorille A. Adaptive biasing force method for scalar and vector free energy calculations. J Chem Phys 2008; 128: 144120.
78. Berrera M, Molinari H, Fogolari F. Amino acid empirical contact energy definition for fold recognition in the space of contact maps. BMC Bioinformatics 2003; 4: 8.
79. Main ER, Jackson SE. Does trifluoroethanol affect folding pathways and can it be used as a probe of structure in transition states? Nat Struct Biol 1999; 6: 831-835.
80. Rennella E, Corazza A, Giorgetti S, Fogolari F, Viglino P, Porcari R, Stoppini M, Bellotti V, Esposito G. Folding and fibrillogenesis: clues from beta2-microglobulin in aqueous trifluoroethanol. J Mol Biol 2010; in press.
81. Roccatano D, Colombo G, Fioroni M, Mark AE. Mechanism by which 2, 2, 2-trifluoroethanol/water mixtures stabilize secondary-structure formation in peptides: a molecular dynamics study. Proc Natl Acad Sci USA 2002; 99: 12179-12184.
82. Yamamoto S, Hasegawa K, Yamaguchi I, Goto Y, Gejyo F, Naiki H. Kinetic analysis of the polymerization and depolymerization of beta(2)-microglobulin-related amyloid fibrils in vitro. Biochim Biophys Acta 2005; 1753: 34-43.
83. Kad NM, Thomson NH, Smith DP, Smith DA, Radford SE. beta2-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J Mol Biol 2001; 313: 559-571.
84. Reimer U, Scherer G, Drewello M, Kruber S, Schutkowski M, Fischer G. Side-chain effects on peptidyl-prolyl cis/trans isomerisation. J Mol Biol 1998; 279: 449-460.
85. Trovato A, Chiti F, Maritan A, Seno F. Insight into the structure of amyloid fibrils from the analysis of globular proteins. PLoS Comput Biol 2006; 2: e170.
86. Trovato A, Seno F, Tosatto SC. The PASTA server for protein aggregation prediction. Protein Eng Des Sel 2007; 20: 521-523.
87. Zhang Z, Chen H, Lai L. Identification of amyloid fibril-forming segments based on structure and residue-based statistical potential. Bioinformatics 2007; 23: 2218-2225.
88. Wang G, Dunbrack RL. PISCES: recent improvements to a PDB sequence culling server. Nucleic Acids Res 2005; 33: W94-98.
89. Kabsch W, Sander C. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers 1983; 22: 2577-2637.
90. 2-microglobulin in comparison with its native fold. Biochim Biophys Acta 2005; 1753: 51-63.